The armamentarium of therapeutic modalities in acute myeloid leukemia (AML) has taken several strides in the last few years as...

Latest therapies in AML: IMGN632, magrolimab & gilteritinib

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review!  For more news visit www.vjhemonc.com

Medicine

Health & Fitness

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

Share Latest therapies in AML: IMGN632, magrolimab & gilteritinib

Sign up to save your podcasts

Latest therapies in AML: IMGN632, magrolimab & gilteritinib

Latest therapies in AML: IMGN632, magrolimab & gilteritinib